To further validate METTL5's role in HCC, an in vivo subcutaneous tumorigenesis model was established using HepG2 cells grown in SMMC‐7721 and METTL5‐sh cells in nude mice. The gene discussed is METTL5; the disease is hepatocellular carcinoma.